Lab
Sonic Reference Laboratory, INC
Sonic Reference Laboratory, INC was paid $1.55M by Medicaid between Jan 2018 and Sep 2024, across 17 billing codes. Its largest line is 81514, — 59% of everything it billed.
33Billing provider infoSONIC REFERENCE LABORATORY, INC
AUSTIN, TX 78728
AUSTIN, TX 78728
33aNPI1174925440assigned 09/18/2014
33bProvider typeClinical Medical Laboratory
28Total paid$1.55M
24GClaims27,259
24DCodes billed17
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Texas
Rank by total paid#53 of 436
Median peer was paid$17K
This provider vs. median90×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,147 | $215K | |
| 2019 | 6,766 | $210K | |
| 2020 | 7,453 | $148K | |
| 2021 | 3,221 | $370K | |
| 2022 | 2,041 | $214K | |
| 2023 | 2,136 | $299K | |
| 2024incomplete | 495 | $99K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 81514 | 59% | 4,563 | 4,193 | $921K | |
| 87481 | 10.0% | 5,759 | 1,245 | $155K | |
| 87529 | 7.9% | 4,211 | 2,054 | $123K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 7.4% | 6,055 | 979 | $116K |
| 87662 | 4.6% | 1,475 | 779 | $72K | |
| 87799 | 3.3% | 1,008 | 386 | $51K | |
| 87511 | 1.5% | 921 | 905 | $24K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 1.5% | 141 | 139 | $24K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.4% | 411 | 375 | $22K |
| 87512 | <1% | 405 | 400 | $15K | |
| 80349 | <1% | 1,425 | 1,325 | $15K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 90 | 67 | $6K |
5 more codes
| 80183 | <1% | 329 | $3K | |
| 83698 | <1% | 94 | $3K | |
| 80177 | <1% | 266 | $3K | |
| 87563 | <1% | 70 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 36 | $300.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCARTER, ANTHONY (PRESIDENT)